SMA (smooth muscle antibody) (97.2%) and Desmin (94.5%) are positive in most smooth muscle tumor patients, serving as markers of smooth muscle cells and being helpful in confirming myogenic tumors (11). This evidence concerns the gene SMN1 and smooth muscle tumor.